Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride

New Delhi, Nov 7 (UNI) Pharmaceutical major Aurobindo Pharma Ltd today said it has received final approval from the US Food and Drug Administration (USFDA) to make and market a 20 mg dose of Sertraline Hydrochloride.

Sertraline, a generic equivalent of Pfizer's Zoloft, is used in the treatment of depressive disorder in adults, a company statement said.

UNI AK SG PM1923